Gemina Laboratories Ltd.
GLAB
Rank in Stocks
#35736
Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the... Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the research, development, and commercialization of in-vitro diagnostics. The firm invents innovative surface functionalization chemistries for identifying pathogens and biomarkers. Among its current projects, Gemina is advancing the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip specifically designed to detect active COVID-19 infections. The company maintains its headquarters in Vancouver, Canada.
Share Price
$0.04377166
Last synced: 2026-02-05
Market Cap
$3.35M
Change (1 day)
-0.30%
Change (1 year)
-81.04%
Country
CA
Trade Gemina Laboratories Ltd. (GLAB)
Category
Healthcare
Operating Margin for Gemina Laboratories Ltd. (GLAB)
Operating Margin as of 2026 TTM: 0.00%
According to Gemina Laboratories Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Gemina Laboratories Ltd. from 2026 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.